Recommended
Recommended
More Related Content
Similar to Newborn Solutions
Similar to Newborn Solutions (20)
More from brand44
More from brand44 (20)
Recently uploaded
Recently uploaded (20)
Newborn Solutions
- 1. Javier Jimenez Co-founder & CEO javier.jimenez@newborn.solutions http://newborn.solutions | +34 626 536 144 Non-invasive serous fluids infections screening, diagnosis & monitoring 2020 1st Place MedTech EIC Accelerator & JU KDT javier.jimenez@newborn.solutions +34 626 536 144 Confidential document
- 2. FULLY AUTOMATIC 20 SECONDS 1 NON-EXPERT USER SAVINGS UP TO 47% Confidential document CONSUMABL E AI MODELS 30.000 images novel material GRANTED: PCTEP2016072125 FILED: 202330177 PAT & FTO: POSITIVE FILING: EXP. JUN23 PAT & FTO: POSITIVE FILING: EXP. APR23 Non-invasive serous fluid white blood cell counter
- 3. 3 BY PROTOCOL: LUMBAR PUNCTURE • Cost-efficiency study by Utrecht Medical Center • Balada-Llassat, et al. Cost of managing meningitis and encephalitis among infants and children in the United States. Diagnostic Microbiology and Infectious Disease 93 (2019) 349–354 • Hcupnet USA public database (https://hcupnet.ahrq.gov/#setup) 95% are negative Up to 50% fail 1 B€ in EU* Confidential document INFANT MENINGITIS 95% ARE NEGATIVE BUT CAN’T MISS A CASE IN LMIC MISDIAGNOSIS LEADS TO 50% MORTALITY Confidential document Scientific references available upon request. INDIA: x10 INCIDENCE PARTIAL VACCINATION COVERAGE
- 4. 4 SUSPECTED MENINGITIS IN INFANTS NON-INVASIVE, QUICK & EASY CLINICAL POC RESULTS: 100% SENSITIVITY & 90% SPECIFICITY Confidential document Scientific references available upon request.
- 5. UVEITIS CAUSES 10% BLINDNESS & 50% VISUAL LOSS EARLY DETECTION & ACCURACY DEPENDS ON EXPERT Confidential document Scientific references available upon request. INDIA: 9.2 M BLIND 270 M VISION LOSS
- 6. 6 USER-INDEPENDENT & ACCURATE SINGLE-CELL RESOLUTION ON CLOSED EYELID Confidential document
- 7. HOME-BASED PERITONEAL DIALYSIS 40% GET INFECTED | MARKET STILL GROWS Confidential document Scientific references available upon request. INDIA: “…is the ideal renal replacement therapy for resource-poor India…”
- 8. 8 HOME-BASED PERITONEAL DIALYSIS EARLY DETECTION & ALERT LAB-BENCH RESULTS: 100% SENSITIVITY & SPECIFICITY Confidential document
- 9. 2023:CURRENT STANDARD 2024: NEW STANDARD 2025: IN THE PIPELINE 20B€ MK OPPORTUNITY | CAGR >5% Confidential document
- 10. OBJECTIVES Regulatory pathway Market Access definition Clinical Usability & Economic Analysis On-site technical support 1 2
- 11. Confidential document TEAM Management and Team International KOLs Distribution in Spain (Shareholders) International advisors (Industry & VC leaders) Jordi Pie BSc Business Commercialisation in health sector SPAIN A. Gubbini Ex-Global Transducers Business Operations Officer MSc, MBA FDA, manufacturing Wim van de Vooren Director of Clinical Marketing BSc EU commercialization of ultrasound systems KOL Infant Meningitis and Malaria Global Health (Gates, OMS, MSF, etc.) Dr. Quique Bassat KOL Infectious Diseases Spanish Drug & Medical Devices Agency Advisor Dr. Cristina Calvo Pediatrician U/S expert EMA Spanish representative EU network Dr. Fernando Cabañas Peritoneal Dialysis Dr. Slon Roblero 25 years Financial Director Pablo García Founder, CFO Economist Problem solver, fundraising Javier Jiménez Founder, CEO PhD, MBA 10 years CE Marking Rita Quesada Quality & Regulatory lead PhD, MSc Val Pironneau Communic. Director MA R Serrano Mechanical systems BA Sc G Navarro & M. Navarrete Software Engineer PhD, MSc F Santos Materials Lead PhD, MSc B Jobs Data Scientist PhD, MSc F Carandell Data Engineer BSc S Ajanovic Medical Director PhD, MSc H Kichou Electronics Engineer PhD, MSc Dr. Quero Dr. Ramon Anglada Surgeon, Uveitis expert Uveitis Meningitis Financial strategy and attraction Christian Carroll Funding & Exit strategy MBA Belen Lopez CFO MSc Corporate Venture Startup Unit head / Specialist home-based dialysis
- 12. Non-invasive serous fluids infections screening, diagnosis & monitoring Barcelona Science Park C/Baldiri Reixac 4-12 Cluster II javier.jimenez@newborn.solutions https://newborn.solutions | +34 626 536 144 Confidential document
Editor's Notes
- Meningitis can kill in hours… But detecting one single case justifies… What if meningitis could be ruled in/out in seconds?
- The device is placed on the fontanelle, the área of the head where the bones…
- Uveitis causes 10% of blindness cases Here, early detection and accurate grading of the disease stage is of utmost importance to prevent blindness But this relies heavily on the expertise of the ophthalmologist, which you will not likely find in emerfency departments or non-tertiary hospitals
- Neosonics can detect individual cells thought the closed eyelid, in the blink of an eye!
- HBPD is a growing market despite the fact that 40% of patients get infected at home And detection of infection depends on the user who must check the color change of the bag, but that can be too late With peritonitis having a mortality rate of 20%. Please, note this dialysis bag…
- Our device can detect infection much earlier and alert the patient and the doctor in no time, making home-based treatment a safer option while costs are reduced.
- There are more applications and other developments and a demo we will be pleased to share with you in our booth
- As you know already I am the CEO, I was recognized as the Spanish Innovator Under 35 in 2016 by MIT, and built the team that has brought the Project from idea to clinical validation within two years thanks to the unique convergence of clinical, technical and regulatory know-how we have. And we will continue to advance by pulling from our advisors their vast experience in industrialization, ultrasound and business also in the health sector and by continuing collaborating with top-level research institutions, hospitals and industry leaders.
- Or in our lab in the Barcelona Science Park.